CAT decides on another TEP - but "not combined" ATMP/device
This article was originally published in Clinica
Executive Summary
Adult skeletal muscle-derived cells intended for treating female stress urinary incontinence should be classified as a tissue-engineered product (TEP) within the context of the Advanced Therapies Medicinal Products (ATMP) Regulation, but not as a combined device/ATMP.